MRK vs SCYX · P/E 33, rev $16.61B vs rev $235.0K
Merck & Company Inc (MRK) versus Scynexis Inc (SCYX) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Scynexis Inc (SCYX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported SCYX revenue for 2026-06-30 was $235.0K. Net income was $7.4M. SCYX currently screens at market cap $37.7M.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. SCYX currently screens at market cap $37.7M.
Not investment advice. Open the MRK and SCYX stock pages for the full models.
Not investment advice.